Related Experiment Video
Updated: Jun 17, 2026
12:21
Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Alpha1-adrenoceptors modulate citalopram-induced serotonin release
Kieran Rea1, Joost Folgering, Ben H C Westerink
1Department of Pharmacology, National University of Ireland, Galway, Ireland.
Neuropharmacology
|January 2, 2010
Summary
Noradrenaline alpha1-adrenoceptors modulate serotonin (5-HT) levels, particularly after SSRI administration. Blocking these receptors reduces serotonin increases in key brain areas, indicating their regulatory role in serotonergic neurotransmission.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Noradrenaline is suggested to regulate serotonergic (5-HT) neurotransmission.
- The precise mechanism of alpha1-adrenoceptor involvement in serotonergic pathways remains under investigation.
Purpose of the Study:
- To investigate the role of alpha1-adrenoceptor manipulation in modulating extracellular serotonin levels.
- To examine these effects in the ventral hippocampus, prefrontal cortex, and raphe nuclei.
- To assess interactions with selective serotonin reuptake inhibitor (SSRI) administration.
Main Methods:
- Microdialysis coupled with High-Performance Liquid Chromatography (HPLC) was employed.
- Alpha1-adrenoceptor manipulation involved prazosin (antagonist), cirazoline (agonist), and reboxetine (noradrenaline reuptake inhibitor).
- Experiments were conducted in the presence and absence of the SSRI citalopram.
Main Results:
- Citalopram administration significantly increased extracellular serotonin in the prefrontal cortex, ventral hippocampus, and raphe nuclei.
- Alpha1-adrenoceptor blockade with prazosin attenuated citalopram-induced serotonin increases in the prefrontal cortex and ventral hippocampus.
- Alpha1-adrenoceptor activation with cirazoline or reboxetine further elevated serotonin levels, an effect blocked by prazosin pre-treatment.
Conclusions:
- Alpha1-adrenoceptors play a significant modulatory role in regulating serotonin levels, especially following acute SSRI administration.
- These findings highlight the interaction between noradrenergic and serotonergic systems in brain regions crucial for mood regulation.
- The data suggest alpha1-adrenoceptors are key targets for understanding and potentially influencing SSRI efficacy.
Related Concept Videos
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...